Integer (NYSE:ITGR) is scheduled to release its earnings data before the market opens on Thursday, May 2nd. Analysts expect Integer to post earnings of $0.80 per share for the quarter. Integer has set its FY19 guidance at $4.05-4.25 EPS.
Integer (NYSE:ITGR) last posted its earnings results on Thursday, February 21st. The medical equipment provider reported $1.04 EPS for the quarter, topping the consensus estimate of $0.92 by $0.12. The company had revenue of $303.00 million during the quarter, compared to the consensus estimate of $301.25 million. Integer had a net margin of 12.88% and a return on equity of 12.56%. The firm’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 earnings per share. On average, analysts expect Integer to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
NYSE:ITGR opened at $68.70 on Thursday. The company has a quick ratio of 1.37, a current ratio of 2.53 and a debt-to-equity ratio of 0.84. The stock has a market cap of $2.31 billion, a PE ratio of 18.08 and a beta of 0.98. Integer has a one year low of $54.20 and a one year high of $92.61.
Several research firms have recently commented on ITGR. Zacks Investment Research downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. ValuEngine downgraded shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Finally, Royal Bank of Canada boosted their target price on shares of Integer from $84.00 to $92.00 and gave the stock a “sector perform” rating in a research report on Monday, February 25th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Integer presently has a consensus rating of “Buy” and a consensus price target of $89.40.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Read More: QQQ ETF
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.